Skip to main content

Table 1 Parameter definitions and values

From: A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement

 

Definitions

Value(range)

Reference

c

Mosquito biting rate

0.8(0.3,1)

[21, 35]

β d

Mosquito-to-human transmission probability of dengue

Varied ∗ (0.045,0.32)

[21, 35]

β z

Mosquito-to-human transmission probability of Zika

Varied ∗ (0.125,0.281)

[21, 35]

η d

Human-to-mosquito transmission probability of dengue

0.5(0.3,0.75)

[21, 35]

η z

Human-to-mosquito transmission probability of Zika

0.5(0.3,0.75)

[21, 35]

γ d

Recovery rate of humans infected with dengue

0.2(0.017,0.33)

[35]

γ z

Recovery rate of humans infected with Zika

0.2(0.14,0.33)

[36–38]

μ

Mosquito mortality rate

0.1(0.028,0.25)

[21, 35]

κ

Antibody dependent enhancement/neutralization factor

Varied (0,3)

[7–9, 32, 33]

 

of the susceptibility of ZIKV

  
  1. * βd and βz are calculated from varied values of Rd∈(1.2,3.2) and Rz∈(2,3)